Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL0175 in Advanced Breast Cancer
NCT07658183Phase 2Recruiting
- Sponsor
- Shanghai Best-Link Bioscience
- Start
- Sep 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of BL0175 in breast cancer, sponsored by Shanghai Best-Link Bioscience. Started Sep 2026; status: recruiting.
02
Drugs
BL0175
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07658183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07658183.